Microneedle patch with programmable release of psoriasis treatment drug and preparation method thereof
A technology for the treatment of drugs and psoriasis, which is applied in the field of microneedle patch and its preparation, can solve the problems of uneven drug distribution, reduction, and inability to meet the long-term treatment needs of moderate to severe patients, and achieve rapid onset of effect, improvement of Effects of uniform, rapid and long-acting psoriasis treatments
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0032] Include the following steps:
[0033] 1. Use a laser engraving machine to etch out a 10*10 polydimethylsiloxane (PDMS) negative template with a bottom diameter of 200 μm, a height of 850 μm, and a distance between adjacent microneedles of 600 μm;
[0034] 2. Prepare a mixed solution of 10 mg / mL methotrexate and 5 mg / mL poly(lactide-co-glycolide) in chloroform, then pass through the membrane with a 0.45 μm filter membrane to obtain a coated Nanoparticles of methotrexate (in these nanoparticles, the poly(lactide-co-glycolide) component is outside and the methotrexate component is encapsulated); the size of the nanoparticles is directly affected by the pore size of the filter membrane , the pore size of the filter membrane can be adjusted according to the actual needs of the particle size; the methotrexate used in this step corresponds to the psoriasis drug that can be slowly released in subsequent applications, and the methotrexate used The specific concentration and vol...
Embodiment 6
[0040] The microneedles prepared in the above-mentioned Example 1 were used on severe psoriasis model mice, and a microneedle patch of a 10*10 array was used every 3 days, and the therapeutic effect was observed after 3 weeks for liver toxicity (alanine aminotransferase , aspartate aminotransferase levels). image 3 The results (Ki67) of middle tissue section (H&E staining) and skin lesion thickening expression factor show that the present invention has obvious curative effect to the ear skin lesion of treatment psoriasis mouse; Figure 4 The levels of the two enzymes (alanine aminotransferase ALT, aspartate aminotransferase AST) in the liver of the mice did not change significantly compared with those of normal mice without disease, indicating that the present invention has no obvious liver toxicity.
[0041] The "poorly soluble", "soluble" and "easy soluble" in the present invention meet the conventional definitions.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com